BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Minehira D, Takahara S, Adachi I, Toyooka N. Laboratory and practical synthesis of Suvorexant, a selective dual orexin receptor antagonist. Tetrahedron Letters 2014;55:5778-80. [DOI: 10.1016/j.tetlet.2014.08.086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Tsuneki H, Kon K, Ito H, Yamazaki M, Takahara S, Toyooka N, Ishii Y, Sasahara M, Wada T, Yanagisawa M, Sakurai T, Sasaoka T. Timed Inhibition of Orexin System by Suvorexant Improved Sleep and Glucose Metabolism in Type 2 Diabetic db/db Mice. Endocrinology 2016;157:4146-57. [PMID: 27631554 DOI: 10.1210/en.2016-1404] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
2 Xu Z, Yao P, Sheng X, Li J, Li J, Yu S, Feng J, Wu Q, Zhu D. Biocatalytic Access to 1,4-Diazepanes via Imine Reductase-Catalyzed Intramolecular Asymmetric Reductive Amination. ACS Catal 2020;10:8780-7. [DOI: 10.1021/acscatal.0c02400] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
3 Lv X, Pan J, Liu W, Meng X, Chen L, Zhou T, Lin K, Ye D, Zhou W. Identification, synthesis and strategy for minimization of potential impurities in the synthesis of suvorexant. Synthetic Communications 2021;51:2225-36. [DOI: 10.1080/00397911.2021.1930055] [Reference Citation Analysis]